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Exome Sequencing Identifies CCDC8 Mutations
in 3-M Syndrome, Suggesting that CCDC8 Contributes in a
Pathway with CUL7 and OBSL1 to Control Human Growth
Dan Hanson,1,2 Philip G. Murray,1,2,3 James O’Sullivan,2,3 Jill Urquhart,2,3 Sarah Daly,2,3
Sanjeev S. Bhaskar,2,3 Leslie G. Biesecker,4,5 Mars Skae,3 Claire Smith,6 Trevor Cole,7 Jeremy Kirk,8
Kate Chandler,2,3 Helen Kingston,2,3 Dian Donnai,2,3 Peter E. Clayton,1,3,9 and Graeme C.M. Black2,3,9,*
3-M syndrome, a primordial growth disorder, is associated with mutations in CUL7 and OBSL1. Exome sequencing now identifies muta-
tions in CCDC8 as a cause of 3-M syndrome. CCDC8 is a widely expressed gene that is transcriptionally associated to CUL7 and OBSL1,
and coimmunoprecipitation indicates a physical interaction between CCDC8 and OBSL1 but not CUL7.We propose that CUL7, OBSL1,
and CCDC8 are members of a pathway controlling mammalian growth.3-M syndrome (MIM 273750 and 612921), named after the
three principle geneticists who first described the condi-
tion,1 is an autosomal-recessive condition characterized
by severe postnatal growth restriction that results in signif-
icantly short stature (typical final adult height of 120–
130 cm).1–3 The syndrome is also associated with distinc-
tive facial dysmorphism, including triangular facies,
frontal bossing, midface hypoplasia, fleshy tipped nose,
and full fleshy lips. Prominent heels are also evident in
younger individuals with 3-M syndrome. Skeletal abnor-
malities including slender tubular bones and relatively
tall vertebral bodies are seen in some individuals. The
condition is associated with normal intelligence.1–3 In
2005, autozygosity mapping revealed a 3-M syndrome
locus on chromosome 6p21.1, and pathogenic mutations
in CULLIN7 (CUL7 [MIM 609577]) were subsequently
identified as the primary cause of 3-M syndrome.4–6 More
recently, further autozygosity mapping revealed a second
3-M syndrome locus on chromosome 2q35-q36.1 with
the underlying mutations identified in Obscurin-like 1
(OBSL1 [MIM 610991]).7,8 To date, there have been approx-
imately 100 reported cases of 3-M syndrome.1–8
CUL7 acts as the structural component of an E3 ubiquitin
ligase consisting of SKP1, ROC1, and FBXW8,9 as part of the
proteasomal degradation pathway, whose targets include
the growth factor signaling molecule IRS-1.10 Unlike other
cullin proteins, CUL7 also has nonproteolytic functions,
including interaction with the tumor suppressor p53; loss
of CUL7 activity results in inhibition of p53-mediated
cell-cycle progression.11,12 In contrast OBSL1 is highly
homologous to the giant muscle protein Obscurin and
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myomesin.14 OBSL1 had not been recognized to have
a role in growth. We previously demonstrated that loss of
OBSL1 by siRNA knockdown leads to concomitant loss of
CUL7 in an HEK293 model.7 Huber et al. established that
individuals with 3-M syndrome and OBSL1 mutations
showed significant modulation of Insulin-like growth
factor binding protein 2 (IGFBP2 [MIM 146731]) and
IGFBP5 (MIM 146734) expression.8 These findings sug-
gested that both CUL7 and OBSL1 are likely to exist in
a common pathway7 and that alterations in IGFBPs and
hence changes in IGF levels may contribute to the patho-
genesis of 3-M syndrome.8
We identified individuals of South Asian descent who
had 3-M syndrome and a history of consanguinity and
did not carry CUL7 or OBSL1 mutations (Figure 1A and
Table 1). With institutional ethical approval and informed
consent, whole blood was collected from affected individ-
uals and genomic DNA extracted via standard procedures.
Autozygosity mapping on three such individuals, all
unrelated (3M-1, 3M-2, and 3M-3), using the Affymetrix
Genome-Wide Human SNP Array 6.0, and analysis of
SNP genotype data by the AutoSNPa program15 revealed
a potential third 3-M syndrome locus located on chromo-
some 19q13.2-q13.32. The autozygous region of 7.9 Mb
is flanked by recombinant SNPs rs535840 (45,373,227 bp)
and rs1991722 (53,270,701 bp) (Figure 1B) and contains
301 protein-coding genes. Exome sequencing capture
with the Agilent SureSelect in-solution target enrich-
ment system using the ABI SOLiD 4.0 platform was per-
formed in all three individuals. Filtering of sequence data
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Figure 1. Mutations in CCDC8 Cause 3-M Syndrome
(A) Individuals with 3-M syndrome who have CCDC8mutations: i) 3M-2, ii) 3M-5. Their phenotype is indistinguishable from individ-
uals with CUL7 or OBSL1 mutations.
(B) Region of homozygosity on chromosome 19 common to three affected consanguineous individuals from different families. Analysis
of SNP data from the Affymetrix Genome-Wide Human SNP Array 6.0 was performed by AutoSNPa. Black and yellow bars indicate
homozygous and heterozygous SNP calls, respectively. Isolated heterozygous SNP calls within the larger homozygous region are likely
to correspond to missed calls. The region of common homozygosity is flanked by recombinants at rs535840 located at 45,373,227 bp
and rs1991722 located at 53,270,701 bp, as shown by the red boxes.
(C) Schematic of the third 3-M syndrome critical region and identity of CCDC8mutations. Shown is a genetic map of chromosome 19
highlighting the critical region located between rs535840 and rs1991722 and the relative location of CCDC8within the region. CCDC8
is a single-exon gene encoding a protein of 538 amino acids, and bioinformatic analysis has indicated a coiled-coil domain located
between residues 349–369 and 513–535 and an alanine-rich domain located between residues 299 and 471. Location and chromato-
grams of mutations in CCDC8 in individuals with 3-M syndrome are indicated by arrows.previously generated in-house data identified two different
homozygous duplication variants in individuals 3M-1 and
3M-2 in CCDC8, coiled-coil domain containing protein 8
(Ensembl: ENSG00000169515, RefSeq: NM_032040.3,
GenBank: NC_000019.9). Low sequence coverage for
CCDC8 in 3M-3 prevented identification of a mutation in
this person (Figure S1 available online). Previously uniden-
tified variants within the homozygous 19q13.2-q13.32
region were also identified. However, these were not found
in multiple individuals or not considered to be pathogenic
(Table S1).The AmSanger sequencing of CCDC8 confirmed the identity
of the two variants and also identified mutations in an
additional three families, including individual 3M-3. The
mutations were not identified in 210 ethnically matched
normal control chromosomes. 3M-2 was homozygous for
c.84dup, predicting p.Lys29X, whereas 3M-1, 3M-3, 3M-
4, and 3M-5 were all homozygous for c.612dup, predicting
p.Lys205GlufsX59 (Figure 1C). SNP analysis revealed that
individuals from families 3M-1 and 3M-3 shared a region
of common haplotype surrounding the CCDC8 loci,
suggesting that c.612insG is a possible founder mutationerican Journal of Human Genetics 89, 148–153, July 15, 2011 149
Table 1. Clinical Findings of Individuals with 3-M Syndrome
3-M ID
3M-1a 3M-1b 3M-2 3M-3 3M-4 3M-5
Clinical Features
Gender M M F F M M
Birth weight (g) 2200 2500 2400 2100 900 2150
Birth weight SD 3 2.2 2.6 3.1 6.3 3.1
Age at initial
presentation (yrs)
2.8 0.4 4 0.65 4.4 0.75
Height SD
at presentation
3 3.5 3.3 6.7 4.8 3.4
Weight SD
at presentation
3.9 4.1 4.3 3.7 5.2 3
OFC SD
at presentation
0 0.9 NA 3.2 NA NA
Radiological Features
Tall vertebral bodies    þ  þ
Slender long bones    þ  þ
Facial Features
Fleshy tipped nose þ þ þ þ þ þ
Anteverted nares þ þ    þ
Full fleshy lips   þ þ  
Triangular face þ  þ þ  þ
Dolicocephaly   þ   þ
Frontal bossing þ  þ þ þ þ
Midface hypoplasia þ  þ  þ 
Long philtrum     þ 
Pointed chin þ þ þ   þ
Prominent ears þ    þ þ
Other Clinical Features
Short neck þ þ   þ 
Winged scapulae      
Square shoulders þ þ    þ
Short thorax þ þ þ þ þ þ
Transverse chest groove þ þ    
Pectus deformity      
Hyperlordosis   þ   þ
Scoliosis      
Hypermobility of joints   þ   
Fifth-finger clinodactyly      þ
Prominent heels þ þ þ þ þ þ
Spina bifida occulta      
Developmental
dysplasia hip
þ   þ  
NA, not available; OFC, occipitofrontal circumference; SD, standard deviation.
Auxology, radiological features, and clinical phenotype of six 3-M syndrome
persons with CCDC8 mutations. List of clinical features from Hanson et al.7
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a premature-termination codon.CCDC8 comprises a single
exon, so neither variant would be expected to lead to
nonsense-mediated decay; we predict that the mutations
would generate truncated CCDC8 with subsequent loss
of function. For further verification of both variants, the
coding sequence of CCDC8 was analyzed in exome-
sequencing data in a control set of 401 persons enrolled
in the ClinSeq cohort.16 DNA was captured with the
Agilent SureSelect system and sequenced as described.17
Both variants were absent from 401 control individuals
in the ClinSeq cohort; however, four SNPs in CCDC8
were identified (Table S3). CCDC8 includes an alanine-
rich domain and has several putative coiled-coil domains
(Figure 1C). BLAST revealed that the N-terminal region of
CCDC8 shares similarity to the N-terminal region of the
Paraneoplastic Ma antigens (PNMA) family of proteins.
Coiled coils have been identified in both transcription
factors and structural cytoskeletal proteins. The function
of CCDC8 has not been defined, but its association to
3-M syndrome indicates a key role in human growth.
We generated a skin fibroblast cell line from individual
3M-2 and cultured it under standard conditions, and we
demonstrated by immunoblotting that CCDC8 was not
detectable. Both wild-type control fibroblasts, as well as
those derived from individuals 3-M syndrome who had
either CUL7 or OBSL1 mutations, had comparable levels
of CCDC8 (Figure 2A). This suggests that CCDC8 muta-
tions in individuals with 3-M syndrome are highly likely
to be pathogenic and that loss of either CUL7 or OBSL1
does not significantly alter CCDC8 levels. We have also
confirmed that a human CCDC8 exogenously expressed
clone runs at the samemolecular mass (~90 kDa) as endog-
enous CCDC8 (Figure 2A). Bioinformatic analysis of
CCDC8 reveals a number of posttranslational modification
sites, including amidation, glycosylation, phosphoryla-
tion, and myristalation (data not shown), which may
explain the shift in molecular mass from the expected
59 kDa.
RT-PCR analysis detected CCDC8 expression in a wide
range of human adult tissues but with low expression in
spleen, skeletal muscle, small intestine, kidney, and liver
(Figure 2B). Analysis of gene expression data using the
UCLA Gene Expression Tool (UGET)18 and a publicly avail-
able resource of Affymetrix microarray data sets (Celsius)19
shows a strong correlation between both CUL7 and OBSL1
expression and CCDC8 expression (data not shown).
To investigate the physical associations of CUL7, OBSL1,
and CCDC8, coimmunoprecipitation assays were per-
formed. We cotransfected CUL7 with OBSL1, CUL7 with
CCDC8, and OBSL1 with CCDC8, overexpressing plasmid
constructs into HEK293 cells. Using this technique, we
found that Myc-CUL7 was recovered from immunoprecip-
itates of coexpressed V5-OBSL1. We also established that
CCDC8 was recovered from immunoprecipitates of coex-
pressedV5-OBSL1.We further confirmed these interactions
by using immunoprecipitates of Myc-CUL7 and CCDC8.011
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Figure 2. Molecular Characterization of CCDC8
(A) Immunoblot analysis of CCDC8 reveals loss of CCDC8 in an individual with 3-M syndrome and a CCDC8 mutation. HEK293 cells
were transfected with a CCDC8 clone 24 hr before harvesting for both cytoplasmic and nuclear fractions. Human skin fibroblasts from
controls and individuals with 3-M syndrome who have CUL7, OBSL1, or CCDC8 mutations were also harvested for cytoplasmic and
nuclear fractions via standard protocols. Direct immunoblotting was performed for CCDC8 (Abnova) and loading was controlled by
GAPDH (Santa-Cruz), demonstrating that individuals with 3-M syndrome who have either CUL7 or OBSL1 mutations have normal
levels of CCDC8, whereas CCDC8 was undetectable in individual 3M-2.
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These data suggest that CUL7 and OBSL1 are physically
associated in vitro while at the same time determining
that OBSL1 and CCDC8 also interact. However CUL7 and
CCDC8 do not interact in this system (Figure 2C).
Our identification of mutations in CCDC8 as a cause of
3-M syndromebroadens thehypothesis that 3-M syndrome
is a disorder of a common growth pathway comprising at
least CUL7, OBSL1, and CCDC8. The interaction studies
suggest that OBSL1 may act as the adaptor protein linking
CUL7 and CCDC8, and indeed, this is consistent with its
previously postulated function. Previously, Geisler et al.13
showed that OBSL1 originates from a genomic duplication
and rearrangement of obscurin prior to the evolution
of teleost zebrafish. On the other hand, CUL7 and its
closely related homolog CUL9 are found as a single gene
in Xenopus tropicalis, a probable duplication event giving
rise to separate genes for CUL7 and CUL9 in higher verte-
brates. CCDC8 is also only present in placental mammals.
We propose that CUL7, OBSL1, and CCDC8 are vital to
the control of mammalian growth.Supplemental Data
Supplemental Data include one figure and three tables and can be
found with this article online at http://www.cell.com/AJHG/.Acknowledgments
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